Transpara 1.3.y
Transpara 1.3.y is a X-ray image interpretive software (FDA Class II; FDA product code QDQ) made by Screenpoint Medical B.V., cleared under FDA 510(k) K181704 on 21 Nov 2018 and listed in FDA GUDID since 4 Feb 2019 (UDI-DI 08719326450100), active as of 23 Oct 2026.
Active
510(k)
Valid until
No expiry
FDA recalls
None found
Documents
Trust
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | GUDID listing | Number08719326450100 | Date4 Feb 2019 | StatusListed |
| United States | FDA 510(k)SESE | NumberK181704 | Date21 Nov 2018 | StatusActive |
Official records
- AccessGUDID record 08719326450100
- FDA 510(k) database K181704
From the FDA record
- Device description
- The ScreenPoint Transpara system is intended for use as a concurrent reading aid for physicians interpreting screening mammograms, to identify regions suspicious for breast cancer and assess their likelihood of malignancy. Output of the device includes marks placed on suspicious soft tissue lesions and suspicious calcifications; region‐based scores, displayed upon the physician’s query, indicating the likelihood that cancer is present in specific regions; and an overall score indicating the likelihood that cancer is present on the mammogram. Patient management decisions should not be made solely on the basis of analysis by Transpara.
- MRI safety
- Labeling does not contain MRI Safety Information
- Natural rubber latex
- No latex statement on the label
- Sterility
- Supplied non-sterile
Across registries
- FDA 510(k) K181704 decided 21 Nov 2018 Active
- FDA GUDID UDI-DI 08719326450100 listed 4 Feb 2019 Listed
Timeline
- Cleared FDA 510(k) K181704
- Listed FDA GUDID 08719326450100
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — FDA 510(k) Active
Specification
- Trade name
- Transpara
- Generic name
- X-ray image interpretive software
- Model / reference
- 1.3.y
- Primary DI / UDI-DI
- 08719326450100
- 510(k) Number
- FDA product code
- QDQ
- GMDN term
- X-ray image interpretive software
- Device class
- Class II
- Regulation number
- 892.2090
- GUDID distribution status
- In Commercial Distribution
Similar devices
Other devices filed under FDA product code QDQ (Radiological Computer Assisted Detection/Diagnosis Software For Lesions Suspicious For Cancer).
- Saige-Dx by DEEPHEALTH
- BU-CAD by TaiHao Medical Inc.
- Lunit INSIGHT DBT v1.1 by Lunit Inc.
- MammoScreen® (4) by Therapixel
- qCT Lung (v1.0) by Qure.Ai Technologies Pvt., Ltd.
- Genius AI Detection 2.0 by Hologic, Inc.
- Median LCS (internal name) / eyonis LCS (trade name) (1.0) by Median Technologies
- Saige-Dx (3.1.0) by DEEPHEALTH
- MammoScreen® (5) by THERAPIXEL SA
- DeepHealth ProstateAI by Quantib B.V.